Literature DB >> 12576506

Telomerase immortalization upregulates Rab9 expression and restores LDL cholesterol egress from Niemann-Pick C1 late endosomes.

Marc Walter1, Joanna P Davies, Yiannis A Ioannou.   

Abstract

Niemann-Pick C (NPC) disease is a rare recessive lipidosis marked by excessive accumulation of LDL-derived free cholesterol and glycosphingolipids in the late endosomal-lysosomal (E-L) system. Here we report that ectopic expression of human telomerase reverse transcriptase (hTeRT) in human cells leads to an upregulation of the small GTPase Rab9 and its effector p40. Expression of hTeRT in NPC1 cells results in a correction of their cellular phenotype, including clearance of accumulated cholesterol from their E-L system. Specifically, in NPC1-TeRT cells, the transport of cholesterol from the E-L system to the plasma membrane is restored with a concomitant increase in cholesterol esterification. This effect is Rab9-specific since expression of Rab9 in untransformed NPC1 cells also leads to a reversal of their disease phenotype. These effects are also seen in normal TeRT-immortalized cells and it appears that TeRT expression leads to an increase in the transport of molecules, including cholesterol, from the E-L system, and may play a role in increasing cellular proliferation. These results suggest the existence of alternative endogenous therapeutic targets that can be modulated to reverse the NPC1 disease phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12576506     DOI: 10.1194/jlr.M200230-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  29 in total

1.  Proteome-wide dysregulation by PRA1 depletion delineates a role of PRA1 in lipid transport and cell migration.

Authors:  Hao-Ping Liu; Chih-Ching Wu; Hung-Yi Kao; Yi-Chuan Huang; Ying Liang; Chia-Chun Chen; Jau-Song Yu; Yu-Sun Chang
Journal:  Mol Cell Proteomics       Date:  2010-06-30       Impact factor: 5.911

2.  Niemann-Pick C1 functions independently of Niemann-Pick C2 in the initial stage of retrograde transport of membrane-impermeable lysosomal cargo.

Authors:  Stephen D B Goldman; Jeffrey P Krise
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

3.  [Enhanced control of proliferation in telomerized cells].

Authors:  E E Egorov; M V Moldaver; Kh S Vishniakova; S M Terekhov; E B Dashinimaev; I B Cheglakov; I Iu Toropygin; K N Iarygin; P M Chumakov; L I Korochkin; G A Antonova; E Iu Rybalkina; I N Saburina; N S Burnaevskiĭ; A V Zelenin
Journal:  Ontogenez       Date:  2007 Mar-Apr

4.  Cholesterol controls lipid endocytosis through Rab11.

Authors:  Miwa Takahashi; Motohide Murate; Mitsunori Fukuda; Satoshi B Sato; Akinori Ohta; Toshihide Kobayashi
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

5.  Elevated endosomal cholesterol levels in Niemann-Pick cells inhibit rab4 and perturb membrane recycling.

Authors:  Amit Choudhury; Deepak K Sharma; David L Marks; Richard E Pagano
Journal:  Mol Biol Cell       Date:  2004-08-03       Impact factor: 4.138

6.  Development of a Rab9 transgenic mouse and its ability to increase the lifespan of a murine model of Niemann-Pick type C disease.

Authors:  Tatiana Kaptzan; Sally A West; Eileen L Holicky; Christine L Wheatley; David L Marks; Tengke Wang; Kyle B Peake; Jean Vance; Steven U Walkley; Richard E Pagano
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

7.  Cellular cholesterol delivery, intracellular processing and utilization for biosynthesis of steroid hormones.

Authors:  Jie Hu; Zhonghua Zhang; Wen-Jun Shen; Salman Azhar
Journal:  Nutr Metab (Lond)       Date:  2010-06-01       Impact factor: 4.169

Review 8.  Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  Orphanet J Rare Dis       Date:  2010-06-03       Impact factor: 4.123

9.  ARF6-mediated endosome recycling reverses lipid accumulation defects in Niemann-Pick Type C disease.

Authors:  Jill Kuglin Schweitzer; Sean D Pietrini; Crislyn D'Souza-Schorey
Journal:  PLoS One       Date:  2009-04-14       Impact factor: 3.240

10.  New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat.

Authors:  James E Wraith; Jackie Imrie
Journal:  Ther Clin Risk Manag       Date:  2009-11-18       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.